Warrants - Schedule of Warrant Activities (Details) |
6 Months Ended |
|---|---|
|
Jun. 30, 2026
$ / shares
shares
| |
| Schedule of Warrant Activities [Line Items] | |
| Number of Options, Expired | shares | (116) |
| Weighted Average Exercise Price, Expired | $ / shares | $ 860 |
| Number of Options, Granted | shares | 701,746 |
| Weighted Average Exercise Price, Granted | $ / shares | $ 177.5 |
| Number of Options, Exercised | shares | (27,491) |
| Weighted Average Exercise Price, Exercised | $ / shares | $ 648.75 |
| Number of Options, Outstanding | shares | 38,085 |
| Weighted Average Exercise Price, Outstanding | $ / shares | $ 2,573.75 |
| Number of Options, Outstanding | shares | 712,224 |
| Weighted Average Exercise Price, Outstanding | $ / shares | $ 1,260 |
| X | ||||||||||
- Definition Represent the weighted average exercise price, outstanding balance. No definition available.
|
| X | ||||||||||
- Definition Represent the weighted average exercise price. No definition available.
|
| X | ||||||||||
- Definition Represent the weighted average exercise price. No definition available.
|
| X | ||||||||||
- Definition Represent the weighted average exercise price. No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Number of non-option equity instruments exercised by participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of shares under non-option equity instrument agreements for which rights to exercise lapsed. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Net number of non-option equity instruments granted to participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|